[Glutathione and N-acetylcysteine in the prevention of free-radical damage in the initial phase of septic shock]
- PMID: 11887346
[Glutathione and N-acetylcysteine in the prevention of free-radical damage in the initial phase of septic shock]
Abstract
The hyperproduction of oxygen free radicals (OFR) and the weakening of natural scavenging mechanisms are implicated in endothelial damage and in multiple organ failure during septic shock. Many authors have proposed the use of antioxidants to decrease OFR damage. Glutathione (GSH) is one of the most important endogenous antioxidants. It plays the role of a sulphydryl group provider for scavenging reactions. N-Acetylcysteine (NAC) is an artificial precursor of GSH which both increases GSH levels and acts as OFR scavenger. The authors carried out a clinical trial to confirm the capacity of high doses of GSH and NAC to cooperate in reducing lipoperoxidative damage in patients with early septic shock. Patients were divided into three groups who received shock therapy only or shock therapy plus GSH or shock therapy plus GSH plus NAC. OFR damage was evaluated by measuring expired ethane, plasma malondialdehyde, complement activation and clinical scores. The study demonstrated that the group who received GSH and NAC showed a significant decrease in peroxidative indexes and an improvement of the clinical scores if compared with the other two groups. In conclusion the administration of high doses of NAC added to GSH significantly decreases the peroxidative stress of patients with early septic shock.
Similar articles
-
The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock.Am J Respir Crit Care Med. 2000 Jun;161(6):1907-11. doi: 10.1164/ajrccm.161.6.9903043. Am J Respir Crit Care Med. 2000. PMID: 10852765 Clinical Trial.
-
Pivotal role of glutathione depletion in plasma-induced endothelial oxidative stress during sepsis.Crit Care Med. 2008 Aug;36(8):2328-34. doi: 10.1097/CCM.0b013e3181800387. Crit Care Med. 2008. PMID: 18664787
-
Antioxidant N-acetylcysteine attenuates the acute liver injury caused by X-ray in mice.Eur J Pharmacol. 2007 Dec 1;575(1-3):142-8. doi: 10.1016/j.ejphar.2007.07.026. Epub 2007 Jul 21. Eur J Pharmacol. 2007. PMID: 17825281
-
[N-acetylcysteine in septic shock].Tunis Med. 2011 Oct;89(10):738-44. Tunis Med. 2011. PMID: 22076894 Review. French.
-
[Therapeutic use of N-acetylcysteine in acute lung diseases].Rev Mal Respir. 1999 Feb;16(1):29-37. Rev Mal Respir. 1999. PMID: 10091258 Review. French.
Cited by
-
Role of Imaging Modalities and N-Acetylcysteine Treatment in Sepsis-Associated Encephalopathy.ACS Chem Neurosci. 2023 Jun 7;14(11):2172-2182. doi: 10.1021/acschemneuro.3c00180. Epub 2023 May 22. ACS Chem Neurosci. 2023. PMID: 37216423 Free PMC article.
-
The Role of Nrf2 in Cellular Innate Immune Response to Inflammatory Injury.Toxicol Res. 2009 Dec;25(4):159-173. doi: 10.5487/TR.2009.25.4.159. Epub 2009 Dec 30. Toxicol Res. 2009. PMID: 32038834 Free PMC article. Review.
-
Dynamic changes in amino acid concentration profiles in patients with sepsis.PLoS One. 2015 Apr 7;10(4):e0121933. doi: 10.1371/journal.pone.0121933. eCollection 2015. PLoS One. 2015. PMID: 25849571 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources